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Abstract 
PrimPol, (Primase-Polymerase), the most recently identified eukaryotic polymerase, has 
roles in both nuclear and mitochondrial DNA maintenance. PrimPol is able to act as a DNA 
polymerase, with the ability to extend primers and also bypass a variety of oxidative and 
photo-lesions. In addition, PrimPol also functions as a primase, catalysing the preferential 
formation of DNA primers in a zinc finger-dependent manner. Although PrimPolʼs catalytic 
activities have been uncovered in vitro, we still know little about how and why it is targeted 
to the mitochondrion and what its key roles are in the maintenance of this multi-copy DNA 
molecule. Unlike nuclear DNA, the mammalian mitochondrial genome is circular and the 
organelle has a number of unique proteins essential for its maintenance, presenting a 
differing environment within which PrimPol must function. Here, we discuss what is 
currently known about the mechanisms of DNA replication in the mitochondrion, the 
proteins that carry out these processes and how PrimPol is likely to be involved in 
assisting this vital cellular process. 
 
  
	   3	  
Mitochondrial DNA – Organisation and structure 
Mammalian mitochondria contain multiple copies (~1000 per cell) of a circular DNA 
molecule (mtDNA) that is ~16.5 Kb in length [1].  Unlike nuclear genomic DNA, virtually the 
entire mtDNA encodes genes that are expressed as 13 proteins, 22 tRNAs and 2 rRNAs 
with no introns. Only two non-coding regions exist, the non-coding region, (NCR), 
containing the origin of heavy-strand DNA replication and the transcription initiation start 
sites HSP and LSP, and OL, the origin of light-strand DNA replication.  
 
Strikingly, significant physical differences exist between the mitochondrial genomes of 
different eukaryotic organisms (Figure 1). For example, most yeast have linear genomes 
ranging in size from ~19 to 150 kb, often consisting of circular permutated copies [2]. In 
plants, the mitochondrial genome varies even more in size, from ~200 kb up to a massive 
11 Mb, due to a large number of introns and duplications (reviewed in [3,4]). In contrast, 
kinetoplast DNA found in the mitochondria of some protists (e.g. trypanosoma) contains 
two types of DNA circles, large maxi-circles (20-40 kb) containing the majority of the 
coding DNA that are catenated with smaller mini-circles (0.5–10 kb), which are essential 
for the production of functional mRNA from the uridylate encrypted maxi-circles [5,6].  
 
In mammalian cells, mtDNA is organised into nucleoid structures containing approximately 
1-2 copies of the genome, although this is likely to vary depending on tissue type and 
energy demand [1,7,8]. Mitochondrial nucleoids are thought to tether mtDNA to the inner 
mitochondrial membrane to aid in organisation, distribution and segregation. Nucleoids 
consist of a number of proteins involved the maintenance of mtDNA but the main DNA 
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packaging protein is TFAM, mitochondrial transcription factor A [9,10]. TFAM is a member 
of the high mobility group (HMG) of proteins, containing two HMG boxes, and is thought to 
condense DNA by inducing bending and then wrapping it into compacted nucleoid 
structures. TFAM forms homodimers with each molecule binding a separate DNA strand in 
order to generate looped structures or to bring different DNA molecules together leading to 
condensation (reviewed in [11]).  
 
One striking feature of mammalian mtDNA is a short triple-stranded region found within 
the NCR, where the addition of a third DNA strand (~0.5 kb), termed 7S DNA, forms a 
stable displacement D-loop structure [12]. The D-loop was first identified in electron 
micrograph images of mtDNA and the 7S DNA was later found and named due to its 
sedimentation rate in caesium chloride gradient studies [12,13]. Despite the length of time 
since the first identification of 7S DNA and the D-loop, we still know little about its actual 
function (reviewed in [14]). Its abundance is found to vary greatly between species and 
tissues, with only 8 % of mtDNA molecules having D-loops in HeLa cells, whilst levels of 
7S DNA are as high as 55 % in human placenta [15]. The D-loop is thought to have a 
number of roles including, acting as a recruitment site for proteins involved in the 
organisation of mtDNA into nucleoid structures [16,17], maintaining dNTP pools 
throughout the cell cycle [18] and functioning as a key component of replication (see 
below). Recent work has shown that this structure may actually be more complex with the 
identification of an RNA strand on the opposing strand to the 7S DNA forming an R-loop, 
which may have a role in the organisation and segregation of mtDNA [19]. 
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A wide range of proteins are involved in the organisation, regulation and replication of the 
mitochondrial genome. All of these proteins are encoded within the nuclear genome and 
must be transported into the organelle as required. Initially, only a small number of 
specialised proteins were thought to be required for these processes but, as techniques 
have improved, we are now identifying numerous additional factors that play roles in the 
maintenance of mtDNA. Many of these proteins function in both nuclear and mitochondrial 
compartments, such as DNA2, Fen1, PIF1, Rad51C and XRCC3, some require 
specialised isoforms, such as Fen1 and PIF1 while others use the same isoform to 
perform these dual roles [20,21,22,23,24,25,26]. 
 
PrimPol- a novel eukaryotic primase-polymerase  
A recent example of such a player is Primase-Polymerase (PrimPol), a newly discovered 
member of the archaeo-eukaryotic primase (AEP) superfamily of primases [27,28,29,30] 
(reviewed in [31,32]). As its name suggests, PrimPol can function both as a primase and 
polymerase. A number of studies have demonstrated that PrimPol is able to generate both 
DNA and RNA primers on single-stranded (ss) DNA templates, albeit with a strong 
preference for dNTPs during synthesis, ~30 fold lower Kd in Mn2+ [28,29,33]. In addition, 
PrimPol is also able to extend a DNA primer in a template-dependent manner and is 
capable of carrying out trans-lesion synthesis (TLS) across a number of different DNA 
lesions, such as 8-Oxoguanine (8-oxoG) and 6-4 photoproducts, (6-4 PP) [28,29]. PrimPol 
contains an N-terminal AEP domain, which contains the key catalytic residues required for 
all its synthesis activities. Its C-terminal UL52-like zinc finger domain is essential for its 
priming activity, probably by stabilising the proteinʼs interaction with ssDNA to allow de 
novo dinucleotide synthesis that is subsequently extended to form a primer [34]. PrimPol is 
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a remarkably unprocessive polymerase, catalysing the insertion of only 1-4 nucleotides 
before disassociating from DNA and is highly mutagenic, particularly prone to produce 
insertion / deletion (indels) errors [34,35,36]. The limited processivity of PrimPol may act to 
limit its mutagenic potential. The elucidation of the structure of the catalytic core of PrimPol 
has highlighted its relatively small active site cleft, with limited contacts formed between 
the protein and the incoming primer strand [37]. 
 
PrimPol is localised in both the nucleus and the mitochondrion, suggesting that it plays 
similar roles in maintaining DNA integrity in both compartments [28,29]. Notably, avian 
cells (DT40) lacking PrimPol exhibit increased sensitivity to a number of DNA damaging 
agents and exhibit a pronounced G2 arrest after exposure to UV damage [28,29]. Loss of a 
PrimPol orthologue (PPL2) in trypanosoma is lethal due to a failure to complete cell 
division in G2/M [38]. In contrast, loss of PrimPol alone is not overtly detrimental to 
mammalian cells, with no obvious signs of damage sensitivity, whilst knockout mice are 
viable and born at mendelian ratios [28,29]. These differences likely reflect the replication 
poise of these cells as DT40 cells are mostly in S-phase, whilst mammalian cells sit 
predominantly in G1. However, human cells become significantly more sensitive to UV 
damage when PrimPol and Pol η, a damage tolerance TLS polymerase, are both absent 
[28,39,40]. Strikingly, loss of PrimPol causes an increase in mtDNA copy number and cells 
exhibit reduced rates of mtDNA recovery after ethidium bromide-induced mtDNA loss, 
suggesting that it is important for maintaining “genome” stability within this organelle 
[29,41]. PrimPol has also been shown to functionally interact with a number of other 
proteins from both nuclear and mitochondrial compartments. These include mtSSB, RPA, 
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PolDIP2 and Twinkle, the mitochondrial helicase, which all appear to play roles in 
regulating PrimPolʼs cellular activities [35,42,43].  
 
However, much is still to be learned about the function of PrimPol in the maintenance of 
replication in both mitochondrial and nuclear compartments. Here, we review what is 
currently know about DNA replication processes in the mitochondrion and discuss how our 
newfound knowledge of PrimPolʼs activities informs us about itʼs possible roles in the 
duplication of mtDNA. 
 
Priming mtDNA replication – how it all begins  
The elusive mitochondrial primase 
To begin replication, DNA must first be ʻprimedʼ by the generation of short primers, which 
the replicase is able to extend. In the nucleus, RNA primers are synthesised on ssDNA by 
the Pol α-associated primase (PriS / Pri1) (reviewed in [44,45]). However, the enzyme 
responsible for the initiation of mammalian mtDNA replication has taken much longer to be 
discovered and we are only now beginning to unravel how this process occurs. A 
mitochondrial primase activity was first identified back in 1985 [46]. This primase activity 
isolated from mitochondria, was distinct from the replicative polymerase γ (Pol γ) and the 
mitochondrial RNA polymerase (POLRMT), and was shown to have the ability to catalyse 
the formation of RNA primers between 9-12 nucleotides long, however the enzyme 
responsible for this activity was not identified [46]. This activity was further characterised to 
show that the primase was able to generate a 5ʼ oligoribonucleotide primer with a 3ʼ 
deoxyribonucleotide termini for polymerase extension and was associated with a structural 
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RNA molecule, which is essential for its activity [47,48]. Although some further insights 
were gained in other species and models of mtDNA replication were proposed, little more 
was learnt about DNA priming or the elusive ʻprimaseʼ for the next 20 years. The subject of 
DNA replication initiation in the mitochondrion was reignited with the discovery that the 
mitochondrial RNA polymerase, POLRMT, was able to initiate lagging strand DNA 
replication in vitro [49]. 
 
POLRMT- a mitochondrial primase 
Mitochondrial RNA polymerase, like the majority of mitochondrial proteins, is encoded 
within the nuclear genome and contains an N-terminal mitochondrial targeting sequence, 
which localises it to this organelle. POLRMT is a single subunit RNA polymerase, which 
shares significant homology with phage RNA polymerases [50,51]. The C-terminal domain 
contains the catalytic core and consists of a number of conserved sequence blocks, which 
form the characteristic thumb and palm structure. Unlike the C-terminus, the N-terminal 
portion of the protein has no sequence similarity to the phage polymerases, instead this 
region is structurally related to the T7 RNA polymerase (reviewed in [52]). This structural 
homology is also mirrored in its functional uses as phage T7 replication employs the RNA 
polymerase in a similar manner to generate RNA primers [53,54,55]. In addition, POLRMT 
contains a unique N-terminal extension, containing a novel penta-peptide repeat domain 
that is essential for promoter-dependent transcription [56]. Unlike T7 RNA polymerase, 
POLRMT is unable to bind to, bend and melt promoter DNA alone and requires a number 
of accessory factors to begin transcription. These factors include TFAM, which is thought 
to alter the DNA structure, allowing initiation, and TFB2M, which interacts directly with the 
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RNA polymerase to aid its recruitment [57,58,59,60,61]. Similarly, yeast mitochondrial 
RNA polymerase Rpo41 requires transcription factor mtf1 for tight DNA binding (reviewed 
in [62]). POLRMT must be targeted to a range of diverse promoter sequences and 
additional factors are likely to be important in its localisation to different structural DNA 
elements (e.g. OL). The generation of POLRMT conditional knockout mice, which have no 
identifiable 7S DNA, confirmed that POLRMT has an essential role in replication initiation 
[63].  
 
Mitochondrial RNA primers (2-10 nucleotides) were first identified at the 5ʼ end of the 7S 
DNA back in 1979 [64]. More recent work has identified that these primers are generated 
by POLRMT [49,65,66], originating from the light and heavy strand promoters LSP and 
HSP, respectively, within the NCR [67,68]. As well as acting as the start site for 
transcription of the mitochondrial genome, LSP was shown to also be the initiation site for 
the formation of a persistent RNA-DNA hybrid, believed to act as a primer for leading-
strand DNA replication [69]. Transcription initiated from the light strand promoter suffers 
two fates, it is either terminated within a region containing three conserved sequence 
blocks (CSBs) and used as a primer for mtDNA replication, or extension continues around 
the mtDNA molecule to form a poly-cistronic transcript, which is then processed further 
[70,71]. The ends of this short RNA were shown to map close to previously identified sites 
of DNA replication initiation and this RNA species was found to be sufficient for the 
initiation of replication in vitro [69,72]. 
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Later work showed that CSB II, a conserved sequence box within the NCR, acted as the  
termination site for transcription, controlling the formation of a primer rather than extension 
to complete transcription [66]. CSB II has the potential to form a quadruplex structure, due 
to its G-rich sequence. However, although this region can form a DNA quadruplex, the 
majority of these species were actually found to form RNA-DNA hybrid intermolecular 
quadruplexes [73,74]. These structures act as strong transcription terminators leading to 
the formation of primers. Thus, the CSB II quadruplex acts as a switch regulating the 
interplay between transcription and replication of mtDNA. Analysis of variation in the CSB 
II region of human mtDNA has shown that sequences that cause only weak termination of 
POLRMT and transcription are avoided. However, all transcription termination events are 
localised to the same downstream sequences, revealing the importance of the 
conservation of this region [75]. Yet, it is still important that when required, these RNA 
molecules are extended into full-length species to provide sufficient mRNA, and therefore 
protein, as required by the organelle. This switch is also partly controlled by human 
transcription elongation factor, TEFM, shown to prevent replication primer formation by 
driving transcription elongation [76,77]. However, the polymerase must then extend the 
primer beyond this quadruplex structure and it has been shown that Pol γ exhibits a much 
decreased extension ability on the CSB II sequence, compared with a mutant CSB II 
sequence that is unable to form a quadruplex structure [73]. In addition, these primer ends 
fall short of the identified 5ʼ ends of newly replicated DNA molecules [78,79], suggesting 
things may not be quite so straightforward, therefore we still have much more to learn 
about the mechanisms that initiate priming of mtDNA replication in the mitochondrion. 
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MtDNA is double-stranded (ds) and therefore replication must also be initiated on the other 
strand. The origin of light strand replication, OL is located approximately two thirds of the 
way around the genome from the NCR and resides in a much smaller non-coding region of 
DNA occupying only 30 bp, between the asparagine and cysteine tRNA genes [80]. 
POLRMT can generate short RNA primers at OL, allowing complete leading and lagging 
strand replication (when combined with Pol γ, Twinkle and mtSSB) of a small circular DNA 
substrate in vitro [49]. Further studies in vivo confirmed that POLRMT is able to prime 
specifically at OL and demonstrated that this specificity is due to a stem loop structure 
formed when the OL sequence is exposed after leading strand replication uncovers this 
region [81]. This stem loop structure is highly evolutionarily conserved and mutations 
affecting its structure are significantly under represented in the mitochondrial genome, 
whilst insertions and deletions in the loop region are well tolerated, confirming the 
importance of such a structure within the mitochondrial genome [82]. 
 
PrimPol, the elusive mitochondrial primase? 
The discovery of PrimPol within the mitochondria raises a number of important questions 
regarding its role as a primase within mtDNA replication [28,29]. Although PrimPol has the 
ability to generate both DNA and RNA primers [28,29], it has a strong preference for 
utilising dNTPs rather than rNTPs to synthesise primers, and studies using PrimPol 
isolated by fractionation of purified mitochondria showed that the enzyme generated DNA 
primers of ~2-12 nt in length [29]. This is in clear contrast to the original activity of the 
historically unassigned ʻmitochondrial primaseʼ thus PrimPol appears not to be this elusive 
protein and suggests there is still much more to be uncovered. If it is not the replicative 
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primase then what are PrimPolʼs primase activities required for within the mitochondrion? 
Mammalian PrimPol is a non-essential protein as knock-out cell lines and mice strains 
have been generated, which exhibited no overt phenotypes [28,39]. Thus, it appears that 
the role of PrimPol can be complemented by other proteins within the organelle or it may 
itself have a “back-up” role, which may be only required under certain particular 
circumstances. Therefore, it is clear that PrimPol is not the main enzyme responsible for 
priming of mtDNA replication and, notably, mtDNA copy number actually increases in the 
absence of PrimPol [28]. It seems more likely that PrimPol acts to reprime DNA synthesis, 
or bypass lesions by TLS, when the replicase is stalled or blocked.  
 
Mitochondrial DNA replication – copying the circle 
Pol γ, the mitochondrial polymerase 
Although a wide range of polymerases are required to replicate and repair nuclear DNA, 
only one polymerase was identified within the mitochondria and this was believed to be 
responsible for all of the replication and repair processes that take place within this 
organelle [83]. Although Pol γ was first identified as early as 1977, it took many more 
years for it to be isolated from Drosophila and confirmed as the key mitochondrial 
replicase due to the abundance of nuclear polymerases [84,85]. Pol γ is a heterotrimeric 
complex consisting of two nuclear-encoded components. PolG1 or A is a 140 kDa subunit 
belonging to the PolA family of polymerases and is thought to share a common ancestry 
with the T-odd polymerase gp5 [86]. It is essential for mtDNA maintenance and its loss is 
embryonic lethal [87]. As well as 5′-3′ polymerase activity, POLG1 also contains a highly 
conserved 3′-5′ exonuclease domain, which confers a key part of its high fidelity, ~100-
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fold greater than that observed for nuclear polymerases [88,89]. In addition, POLG1 also 
has 5′ dRP lyase activity, which allows the enzyme to execute base excision repair, again 
increasing its fidelity and strengthening its role in DNA repair within mitochondria [90]. The 
crystal structure of the Pol γ complex has provided further insights into its mechanism and 
the unique interactions between its subunits. Analysis of a wide number of disease 
causing mutations within the context of this structure has led to a greater understanding of 
the molecular changes that these alterations induce [91,92] (reviewed in [93]). 
 
POLG2 or B, is a 55 kDa homodimeric accessory subunit required for tight binding of the 
holoenzyme on DNA [94]. It is also vital for increasing the processivity of the replication 
complex and interacts with Twinkle at the replication fork [95,96]. POLG2 evolved from 
class IIa aminoacyl-tRNA synthases and appears to be less conserved than its catalytic 
counterpart, with no orthologues identified in fungi [97]. The binding of POLG2 significantly 
increases the processivity of the enzyme due to a change in the structure of POLG1, 
which increases its DNA interaction “footprint” from 10 to 25 bp [91]. The addition of 
POLG2 to the complex decreases the proofreading capacity of the enzyme, which is likely 
due to a decrease in the ability to switch the template DNA from the polymerase to the 
exonuclease active site [88,96]. 
 
The polymerase is assisted in the completion of replication by a number of other 
components including Twinkle, the mitochondria helicase, and MtSSB (SSBP1), a single-
stranded DNA binding protein. More recently, a much wider range of proteins have been 
associated with mtDNA replication and repair, many of which have already been identified 
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based on their roles in nuclear DNA metabolism. These include the helicases DNA2, PIF1 
and RecQL4, topoisomerases TopImt, TopIIIα, TopIIβ [21,22,23,24,98,99,100,101], Fen1, 
DNA ligase III, RNAse H1 [25,102,103,104,105,106]. 
 
Mechanisms of mammalian mtDNA replication  
The first studies of mtDNA replication were carried out using electron microscopy, which 
highlighted a number of unique structures within the observed molecules, including double 
forked structures with one single-stranded branch [107,108,109]. These studies lead to the 
proposal of a strand-displacement model of mtDNA replication [108,110,111]. This model 
proposes that replication continues in an asynchronous, unidirectional manner, replication 
proceeds on the H-strand extending from the primer generated in the NCR region, whilst 
the unreplicated ssDNA becomes coated with mtSSB. After replication has proceeded two 
thirds of the way around the molecule then OL becomes exposed, allowing replication to 
be primed in the reverse direction, again continuing unidirectionally around the circle to 
generate a fully duplicated daughter molecule [112]. 
 
The use of 2D neutral agarose gel electrophoresis (2D AGE) uncovered a second distinct 
replication mechanism of mtDNA replication. This technique relies on the fact that DNA 
can be isolated dependent on its mass and shape by altering separation conditions [113]. 
Strikingly, when mtDNA replication intermediates were examined by this method, a 
number of conventional replication bubbles and forks were observed. These structures 
were resistant to ssDNA nucleases, suggesting a conventional strand-coupled mechanism 
of replication [114,115,116,117]. Although such dsDNA molecules had been observed 
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much earlier in EM images of rat liver mtDNA, a strand-coupled mechanism was not 
pursued [108,109,118,119]. Replication is believed to initiate in a bidirectional manner 
from a broad zone termed ori Z, however, OH acts as a strong replication barrier therefore 
DNA replicases are stalled and unable to pass bidirectionally through this region 
[114,116].   
 
In addition to conventional strand-coupled replication intermediates, 2D AGE also 
identified replication intermediates with significant regions of RNA-DNA hybridisation 
[79,117]. This lead to the proposal of the Ribonucleotide Incorporation ThroughOut the 
Lagging Strand (RITOLS) mechanism of mtDNA replication, where RNA is bound to the 
displaced strand during asynchronous replication rather than mtSSB [79]. This RNA was 
identified as mtDNA transcripts, which are thought to be laid down when the L strand is 
released as ssDNA during replication and in organello labelling allowed these RNA 
species to be followed as replication proceeds [120]. More recent EM studies support this 
model as it was observed that when conditions were optimised to preserve fragile RNA, no 
ss mtDNA regions were present [121]. Variations in the types of replication intermediates 
was observed across different tissues and under different stresses (e.g. damage or 
mtDNA depletion) suggesting that different mechanisms may be utilised under various 
circumstances [122]. 
 
However, there is still much controversy and disagreement over these different replication 
mechanisms, with recent work showing that mtSSB occupancy is increased between OH 
and OL on the displaced heavy strand, favouring the strand-displacement model [123]. 
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Whilst it has been claimed that mtSSB is lost due to proteinase K treatments used to 
observe RITOLS intermediates and that R-loops are prevalent in mtDNA but not 
replication intermediates, others claim RNA loss during preparation leads to mtSSB 
binding [121,123,124]. Although more studies are required to fully unravel the mechanisms 
of mtDNA replication, it seems likely that this process consists of a combination of the 
proposed models.  
 
Although it currently seems unlikely that PrimPol plays a direct role in replicating 
mitochondrial DNA, as it is non-essential in mammalian cells, it probably plays roles in 
maintaining on-going replication when the replicative complex of Pol γ and Twinkle hits an 
obstacle. Cells are clearly able to maintain replication in the absence of PrimPol and, 
notably, the majority of yeast species lack PrimPol orthologues. However, the presence of 
this additional primase-polymerase is likely to aid in overcoming replication barriers thus 
ensuring timely completion of replication. 
 
Damage tolerance during mtDNA replication 
For many years, it was believed that mitochondria did not have their own DNA repair 
proteins / pathways as they were unable to remove CPDs after UV damage [125]. Thus, 
replication must be able to proceed beyond such damage, which is likely to be 
perpetuated within the DNA. However, these original ideas have now been refuted and 
many new players in the maintenance and repair of mtDNA are regularly being added to 
the team of proteins maintaining the “genome” within this organelle. Although a wide range 
of repair pathways are now known to be able to remove DNA lesions within mitochondria, 
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this can be a relatively slow process and therefore Pol γ probably requires additional 
damage tolerance / bypass mechanisms to allow timely progression of replication. 
 
Bypass of lesions- overcoming obstacles on DNA 
Along with its ability to generate primers, PrimPol is also a template-dependent 
polymerase with the ability to bypass some lesions. For example, it has the ability to 
perform TLS bypass of 8-oxoG lesions, a prevalent product of oxidative damage but is 
unable to bypass abasic sites or thymidine glycol lesions unless supplemented with 
manganese [28,29]. In addition, PrimPol has the ability to bypass damage caused by UV 
exposure and, unlike known mammalian polymerases, PrimPol can bypass distorting 6-4 
PPs lesions that induce DNA bending. Although it is not able to directly bypass CPDs in 
the presence of magnesium, it can extend from this lesion when templated with two dA 
residues, unlike many other polymerases [28]. In addition, PrimPol has been reported to 
scrunch the template, realigning the priming strand in order to bypass intolerable DNA 
lesions, which seems the more likely mode of bypass given the proteins small active site 
cleft [36,37]. Thus, it seems likely that PrimPol may also play a role in the TLS bypass of 
these types of damage within the mitochondrial genome (Figure 2).    
 
UV damage has been shown to accumulate in mitochondrial DNA, particularly in skin cells 
that are regularly exposed to low levels of UV irradiation (reviewed in [126]). These lesions 
are commonly repaired by the nucleotide excision repair (NER) pathway [127]. However, 
this pathway has not been identified within the mitochondria therefore such lesions must 
be repaired by other pathways such as BER, MMR, NHEJ or homologous recombination 
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and may even persist within the DNA. To prevent the catastrophic formation of double-
strand breaks during DNA replication, the organelle must have a method to bypass such 
lesions. Studies have shown that Pol γ has the ability to bypass CPD lesions in vitro, albeit 
at a level much lower than that of undamaged DNA [128]. Although it often incorporates 
the incorrect base at such sites, it is still able to excise these mutations using its 
exonuclease domain. However, such methods of bypass either by PrimPol or Pol γ are 
likely to significantly delay the completion of replication. Although the mitochondria has 
multiple DNA copies, unperturbed replication of the full genome is thought to take up to 
one hour [110], therefore only a small amount of damage is likely to have a drastic effect 
on the organelles functionality as a whole. Indeed, although low levels of UV or oxidative 
damage do not affect the mitochondrial DNA copy number, they do cause changes in the 
mechanism of DNA replication [129]. It has been shown that after such UV damage, 
replication switches from a RITOLS mechanism to a strand-coupled mechanism, likely due 
to its ability to complete replication more rapidly and allow mtDNA copy number to be 
maintained in the presence of damage [129]. It is believed that the RITOLS mechanism 
may represent a high fidelity method of genome replication, whilst the strand-coupled 
mechanism may be more error-prone but allow replication to be completed. Notably, 
tissues with a higher oxidative stress load use a higher degree of strand-coupled 
replication[122][129]. However, for strand-coupled replication to be successful, particularly 
in the presence of DNA damage, the replication machinery must be able to generate 
multiple new primers to allow the continuation of the replication fork.  
 
PrimPol can also reprime DNA synthesis after lesions and it is this function that is likely to 
be vital in allowing replication to proceed after DNA stalling. Allowing the replication fork to 
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continue beyond such lesions would significantly decrease the completion time and thus 
allow processes that take a longer time, such as repair of the lesion itself, to take place in 
a post-replicative fashion. PrimPol is a poorly processive polymerase, only capable of 
incorporating 1-4 bases before falling off the DNA, suggesting it may be required to 
produce short primers for the more accurate and exonuclease-containing polymerase, Pol 
γ to take over and complete mtDNA replication. PrimPol interacts with RPA, mtSSB and 
PolDIP2, which modulate its synthesis activities in vitro [35,42]. Although PrimPolʼs 
polymerase activity is stimulated by Twinkle [43], mtDNA replication studies showed that 
PrimPol is unable to enhance replication after Pol γ stalling at oxidative lesions [43]. 
Therefore, although it has the capability to perform TLS in vitro, the jury is still out on 
whether or not PrimPol actually uses such a mechanism to restart replication in vivo.  
In addition, POLRMT may also play a key role in repriming DNA replication within the 
mitochondrion. Although POLRMT has been demonstrated to initiate replication at three 
defined sites in the genome, it is also capable of generating RNA primers on ssDNA 
[49,130,131]. In contrast to PrimPol, it generates RNA primers of ~ 25-75 nucleotides long 
[49,130], although these have been found to be as short as 9-18 nt in yeast in the 
presence of the transcription factor mtf1 [131]. These differences suggest both may play 
key roles in repriming but under different circumstances. 
 
More than one polymerase on the block 
Unlike mammalian mitochondria, which for many years were thought to contain only a 
single DNA polymerase, a number of additional polymerases have been found to also 
reside within yeast mitochondria. Like mammalian mtDNA replication, the main replicative 
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polymerase is a Pol γ homologue, Mip1, that consists only of the large catalytic subunit, 
with no PolG2 homologue identified [132,133]. In addition, Pol α has also been identified 
within the mitochondria in S. cerevisiae [134]. Its dual localisation was confirmed by 
immunofluorescent labelling and, although its function within the organelle is yet to be 
elucidated, it is likely to have a role in repair and gap-filling as it is unable to rescue cells 
lacking Mip1 [134]. In another S. cerevisiae study, Pol ζ, consisting of Rev3, Rev7 and 
Rev1, was also found to localise within the mitochondria as well as in the nucleus. [135]. 
Whilst depletion of Rev3 or Rev7 had no effect on mitochondrial mutation levels, loss of 
Rev1 lead to a decrease in the frequency of spontaneous mutations within the mtDNA. 
[135] Further studies have shown that, although loss of Pol ζ causes a decrease in 
spontaneous and UV-C induced frame-shift mutations, it also causes a large increase in 
point mutations after UV-C damage, suggesting an alternative, more mutagenic, pathway 
is used in its absence [136]. Interestingly, over-expression of Pol ζ is able to rescue 
pathological Mip1 mutants, which cause an increase in mutations [137], whilst over-
expression of the protein in the nucleus causes an increase in mutations [138]. In addition, 
a proportion of Pol η has also been identified within the mitochondria of budding yeast 
[139]. Like Pol ζ, it was also found that loss of Pol η causes an increase in the number of 
mutations produced after UV-C damage within the mitochondrial DNA, confirming an 
important role in the maintenance of DNA integrity. Other organisms have also been found 
to have a much wider range of mtDNA polymerases (Figure 1), with trypanosomes having 
a large number of Pol β and Pol κ-like polymerases [6,140].  
  
New players join the mammalian mitochondria polymerase team  
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A recent study using a mtDNA-specific damaging agent has provided clear evidence for 
additional polymerases within mammalian mitochondria. Pol θ is a member of the A family 
of DNA polymerases but, unlike many of the other members, it is a highly promiscuous 
polymerase that exhibits a wide range of activities on a broad variety of substrates. 
Indeed, it appears to have roles in inter-strand crosslink repair, BER, microhomology-
mediated end-joining (MMEJ), translesion synthesis, as well as having lyase activity 
[141,142,143](reviewed in [144]).  Although it has no mitochondrial targeting sequence, it 
is recruited to the organelle after oxidative damage [145]. Strikingly, loss of Pol θ leads to 
a decrease in cellular oxygen consumption and mitochondrial membrane potential, 
indicative of decreased oxidative phosphorylation, whilst mtDNA actually shows a 
decrease in mutations, suggesting that other types of damage may abound [145]. This is 
not unique, as loss of Pol ζ in the nucleus has a similar effect on mutation levels [146,147]. 
Although these TLS polymerases are useful for maintaining replication across lesions, 
thus preventing the formation of possible DSBs as replication and the cell cycle 
progresses, their ability to perform TLS comes with a high mutagenic cost. Therefore, the 
cell must balance such consequences to ensure that a functional copy of the genome is 
passed on to daughter cells. In the mitochondrion, mutations represent less of a risk than 
in the nucleus, as each gene is available in multiple copies, thus any mutated copy 
represents a much smaller fraction of the available product pool. Although mutations have 
been shown to cause a range of mitochondrial diseases, some with catastrophic 
consequences for cellular survival, these mutations must cross a threshold level before 
their effects are observed. Mitochondrial DNA copy number appears to be relatively 
flexible and it has been reported, in a number of model organisms, that copy number 
varies widely across tissues and with age [148,149]. Interestingly, mtDNA copy number 
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has been found to vary widely across different cancers, likely due to mutations in a 
number of regulatory genes and, in a number of cases, mtDNA copy number has been 
linked to prognostic outcomes [150,151,152]. In addition, it has been reported that high 
levels of random mutations are tolerated by cells. For example, studies on mice lacking 
the exonuclease domain of Pol γ showed premature ageing. However, when mutation 
levels were analysed in the heterozygotes, they were shown to be almost as high as 
homozygote litter mates but showed no premature ageing phenotypes [153].  
In addition, extension of work initially carried out in yeast has shown that a specific isoform 
of Rev3 is also found within mammalian mitochondria, yet unlike in yeast, the other 
components that form Pol ζ have not been identified [154]. Loss of this protein causes 
mitochondrial dysfunction and an increase in DNA damage after UV-C irradiation [154].  
 
It is now becoming clear that, like nuclear DNA maintenance, mitochondria also utilise a 
broad range of repair and tolerance mechanisms to overcome DNA damage, which may 
occur spontaneously or arise due to many different environmental issues. The presence of 
several TLS polymerases within the organelle suggests that mitochondria also utilise such 
specialised polymerases to overcome DNA lesions. As well as direct extension of the 
replication fork, such polymerases are also likely to be vital for post-replicative repair 
across lesions. In many cases where the fork is stalled, replication may be reprimed 
beyond a lesion by PrimPol or POLRMT allowing replication to proceed. However, a 
polymerase able to bypass the lesion is then required to fill in the gap left behind, thus 
allowing repair of the lesion that must be done on dsDNA to prevent the formation of 
double-strand breaks, which are highly deleterious for the cell.  
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DNA structural barriers in mitochondria - bypass of G4 quadruplex structures 
G4 quadruplexes (G4s) are stable DNA secondary structures formed through the planer 
stacking of quartets of Hoogsteen-bonded guanine bases. They are thought to have a 
wide range of roles within cells including, replication initiation, telomere maintenance, 
epigenetic instability, regulated recombination in the immune system and transcription 
regulation [155]. G4s form in both DNA and RNA and can be either intra-molecular, within 
one DNA strand, or inter-molecular, between two or more DNA/RNA strands [156]. Along 
with the well-studied RNA/DNA quadruplex found in the NCR, in silico studies have 
identified a number of other potential G4 forming sequences within mtDNA [157,158]. 80-
90 potential quadruplex forming sequences have been found throughout the human 
mitochondrial genome, strongly biased towards the heavy strand of DNA, which has a 
significantly high content of guanine nucleotides. Yeast mtDNA contains ~0.373 potential 
quadruplex-forming sequences per 1000 base pairs, which is an order of magnitude larger 
than in nuclear DNA (~0.034-0.067) [159,160]. Interestingly, some studies suggest that, 
along with other helix distorting and intrinsically curved regions of DNA, G4s may be a 
significant cause of DNA instability within the mitochondrial genome [161]. Dong et al. 
have identified a number of quadruplexes with 2 or 3 consecutive guanines within the 
mitochondrial genome that are associated with sites of common mitochondrial deletions 
[158]. They proposed that such structures may induce genome deletions in a number of 
possible ways including the stalling of replication, causing DNA breaks or extensive tracts 
of vulnerable ssDNA or through aberrant DNA repair mechanisms [158]. In addition, 
potential quadruplex forming sequences are found close to sites of common pathological 
deletions and such sequences are inefficiently unwound by the mitochondrial helicase, 
Twinkle, suggesting they may cause a significant impediment to progressing replication 
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forks [162]. In addition, a number of other DNA structures may also persist within mtDNA, 
which may slow or stall the replicative polymerase, such as triplex or Z DNA, intrinsically 
bent structures or hairpin loops, such as the loop shown to form at OL [161,163]. 
 
It has recently been demonstrated that PrimPol is crucial for the bypass of G4s in the 
nucleus of vertebrate cells [164]. Although PrimPol is unable to replicate directly through 
these structures, it is capable of repriming directly after G4s in a process termed “close-
coupled repriming” that enables replication to be restarted almost immediately 
downstream of G4s (Figure 2). In the absence of PrimPol, a significant amount of 
uncoupling of the replication fork was observed in cells as large tracts of late replicated 
DNA in the region of the quadruplex on the leading strand, which was associated with the 
loss of epigenetic histone marks [164]. This recent discovery has led to speculate that 
PrimPol is likely to play a similar role in the replication of such structures within the 
mitochondrial genome. Although Twinkle shows poor activity when confronted with G4 
structures [162], a number of helicases have been found to be involved in the bypass of 
such structures in the nucleus, one of which (Pif1) is also localised to the mitochondria 
[21,165].  
 
Tolerance of chain terminating Nucleoside Analogues 
Another situation where PrimPol has recently been shown to play a vital role is in the 
maintenance of replication in the presence of chain terminating nucleoside analogues 
(CTNAs), such as acyclovir and abacavir. Cells lacking PrimPol showed increased 
sensitivity to such drugs, whilst PrimPol was found to be able to incorporate a number of 
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these nucleotide analogues and also perform close-coupled repriming downstream of such 
lesions in vitro [40,166]. CTNAs typically lack the essential 3ʼ hydroxyl moiety required for 
phosphodiester bond formation and therefore prevent on-going replication when 
incorporated into DNA by terminating strand extension. They are commonly used to 
control viral infections, (e.g HIV), as they are readily incorporated into DNA by reverse 
transcriptase, significantly slowing viral replication processes. However, they do have a 
range of toxic side effects caused by mitochondrial toxicity (reviewed in [167,168,169]), 
with long-term use of AZT, (azidothymidine) causing a decrease in mitochondrial DNA in 
skeletal muscle and cumulative mitochondrial myopathy [170,171]. More precisely, these 
affects have been attributed to the incorporation of these nucleoside analogues by Pol γ 
(reviewed in [172]). Pol γ inserts nucleoside analogues with varying ease, some 
incorporated at concentrations similar to standard nucleotides, while others require ~2-5 
fold higher concentrations to be efficiently incorporated [173,174,175]. All analogues share 
the ability to inhibit Pol γ-mediated replication in vitro by preventing any further synthesis 
and therefore they must be rapidly removed otherwise on-going replication is inhibited 
[174]. The attempted removal of CTNAs from the elongating DNA strand is likely to be first 
tackled by the exonuclease domain of Pol γ, whose role it is to check newly replicated 
DNA for accuracy and quickly remove any incorrectly incorporated bases to prevent 
mutations from being generated [88]. The exonuclease domain of Pol γ increases its 
fidelity by improving nucleotide selection by a factor of ~200 [88]. Notably, removal of 
nucleoside analogues by this exonuclease is a slow process. For example, the ddC 
analogue Zalcitidine has a half-life in DNA of ~2.4 hours due to its stronger binding affinity, 
compared to standard nucleotides, for the polymerisation domain [176]. In addition, other 
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analogues (e.g. AZT) have also been shown to inhibit the exonucleolytic activity of Pol γ, 
causing a decrease in fidelity [174].  
Given this propensity for incorporation of CTNAs into replicating mtDNA, it seems likely 
that PrimPol also plays a key role in repriming replication after the incorporation of these 
nucleoside analogues by Pol γ (Figure 2). PrimPol-deficient cells are more sensitive to the 
presence of these analogues and this sensitivity can be complimented by the addition of 
PrimPol, but not by a primase-deficient mutant of this enzyme [40], indicating that 
repriming is essential for this process. In addition, PrimPol is able to reprime downstream 
of incorporated nucleoside analogues in vitro, further supporting this proposed role in 
replication restart. Interestingly, PrimPol is itself able to incorporate a number of the FDA 
approved CTNAs into DNA, albeit less efficiently than natural nucleotides, with a distinct 
discrimination profile compared to Pol γ [166]. Thus, PrimPol may also create its own 
problems, but its low processivity [34] is likely to limit such potential toxicity in vivo. 
 
Conclusions 
Despite its small size, mitochondrial DNA can represent ~1 % of the total DNA in some 
cells due to its polyploid nature [17]. However, our understanding of DNA replication 
processes within this organelle still trails well behind that of nuclear genome duplication. 
Mitochondrial DNA has its own specialised replicative polymerase and mechanisms that 
vary from those observed in the nucleus, although some controversy remains within the 
field over the abundance and validity of the different proposed replication models. 
However, we are beginning to uncover that mtDNA replication and repair mechanisms 
may in fact be more similar to those in the nucleus than was initially thought, as many 
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proteins identified within the nucleus are now also being found to have additional roles in 
mtDNA replication. Clearly, there is much more to understand about the replication of this 
small, but far from insignificant, molecule of DNA.  
PrimPol is likely to play a similar role within the mitochondrion as it does in the nucleus, 
maintaining the progression of the replication fork after replisome stalling. Emerging data 
suggests that PrimPols key role is likely to be in repriming replication restart after a fork 
stalling lesion or DNA structure [40,164]. In this review, we propose that it is highly likely 
that PrimPol plays the same roles in mitochondria by repriming DNA replication to allow 
replication to be completed in an efficient and timely manner (Fig. 2).  
However, mitochondrial DNA organisation varies significantly from the compaction of 
nuclear DNA and therefore the replication mechanisms and proteins required for its 
duplication are adapted for these different environments suggesting that PrimPol must be 
a highly flexible protein, which is able to adapt its functions depending on its partners and 
the problems it encounters. It seems likely that its main role is to reprime the initiation of 
DNA synthesis after Pol γ is stalled by DNA damage, secondary structures or chain 
terminating events. This allows replication to proceed, leaving behind the cause of the 
stalling event to be processed and corrected in a post-replicative fashion. However, its 
ability to perform TLS opposite template lesions, such as 8-oxoG, may also be significant 
[28,29]. Complete replication of a mitochondrial DNA molecule is thought to take ~1 hr 
[110] thus, although each cell contains multiple copies of the mitochondrial genome, it is 
essential that each round of replication is completed in a timely manner to prevent the 
accumulation of multiple stalled and / or collapsed replication forks. Indeed, in the absence 
of PrimPol, the mtDNA copy number is considerably increased suggesting that more 
copies are required to fully maintain organelle functionality. 
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Although we have primarily discussed the possible roles of PrimPol during mitochondrial 
genome replication, it is possible that it may also play additional roles in the repair of 
damaged DNA in the absence of on-going replication. For example, almost all DNA repair 
pathways utilise polymerases to fill in gaps generated by nucleolytic repair processes, 
such as base / nucleotide excision and resection. Notably in this regard, distinct primase-
polymerases have evolved to play such bespoke roles in various DNA repair processes in 
prokaryotes, such as NHEJ [31,32]. We still have much more to learn about the roles and 
regulation of PrimPol in both the mitochondria and the nucleus and further research is 
required to better understand the functions this fascinating enzyme fulfils within the cell. 
[177]  A range of PrimPol mutations have been found in cancer cells and other conditions 
suggesting possible connections to human disease, including mitopathies, although these 
pathological associations remain to be established. [178]. 
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Figure legends  
Figure 1. The diversity of mitochondrial genomes. This table shows the wide variety of 
mtDNA sizes found across different kingdoms and how their organisation and replication 
mechanisms differ. Also highlighted are primases and polymerases shown to be, or 
speculated to be (?), involved in these processes. Black strands represent parental DNA, 
with newly synthesised DNA shown in blue and RNA in red. 
 
Figure 2. Potential functions of PrimPol during mtDNA replication. Highlighted here 
are ways in which PrimPol may play key roles in allowing the maintenance of mtDNA 
replication in a number of fork stalling situations. A. After Pol γ is stalled by a lesion 
(yellow star), PrimPol is able to reprime synthesis downstream to allow replication to 
proceed while the slower process of replication across the lesion is dealt with by Pol γ 
itself or another specialised TLS polymerase. Alternatively, PrimPol may act as a TLS 
polymerase that directly bypasses the lesion. B. PrimPol may play a role in repriming 
synthesis when the replication fork is stalled by DNA secondary structures, e.g. G4s. By 
priming after the structure, it allows replication to continue downstream, while specialised 
helicases are recruited to facilitate synthesis through the structure. C. Nucleoside 
analogues (cyan star), incorporated into the newly synthesised strand, prevent further 
elongation and must be removed by the exonuclease of Pol γ, which is a slow process. 
PrimPol may reprime downstream of CTNAs to allow replication to continue in a timely 
fashion, whilst the process of removing these is completed. In each case, the second DNA 
strand is shown as dsDNA for simplicity, however, this could be coated with mtSSB or 
RNA transcripts, depending on the mode of replication. 
 
 
 
